664 - Attitudes about COVID and Community Engagement with Patients (ACCEPt): Global Survey Reveals the Ongoing Impact of Long COVID-19 on Medically Vulnerable Populations, Five Years On

Presenting Author(s)

• 

  Roger Paredes, MD, PhD (he/him/his)

  Head, Department of Infectious Diseases
  Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain
  Badalona, Catalonia, Spain

  Slides

Co-Author(s)

• JB

  Jennifer Bodie, PhD

  Pfizer Inc.
  New York, New York, United States
• NB

  Nikola Brigden, n/a

  Forgotten Lives
  Hedon, England, United Kingdom
• AC

  Antonella Cardone, n/a

  CEO
  Cancer Patients Europe
  Brussels, Brussels Hoofdstedelijk Gewest, Belgium
• 

  Ashley S. Cha-Silva, PharmD, MS (she/her/hers)

  Director
  Pfizer
  New York, New York, United States
• MF

  Maria Fernandez, PhD, MBA

  Director Global Access & Value--Anti-infectives
  Pfizer
  Chapel Hill, NC, United States
• DG

  Daniel Gallego, n/a

  European Kidney Patients Federation
  Aldaya, Comunidad Valenciana, Spain
• RQ

  Romina Quercia, M.D., Ph.D.

  Pfizer
  London, England, United Kingdom
• JR

  Jason Resendez, n/a

  National Alliance of Caregiving
  Washington, Washington, United States
• DS

  Doris Christiane Schmitt, n/a

  Board Member
  Path Biobank Foundation
  Munich, Bayern, Germany
• FS

  Frank Spinelli, MD

  Global Medical Director
  Pfizer Inc.
  New York, New York, United States
• MV

  Mariano Votta, n/a

  Director
  Active Citizenship Network (Cittadinanzattiva)
  Rome, Lazio, Italy